Title | Transcatheter Thoracic Duct Decompression for Multicompartment Lymphatic Failure After Fontan Palliation. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Smith CL, Dori Y, O'Byrne ML, Glatz AC, Gillespie MJ, Rome JJ |
Journal | Circ Cardiovasc Interv |
Pagination | 101161CIRCINTERVENTIONS121011733 |
Date Published | 2022 Jun 16 |
ISSN | 1941-7632 |
Abstract | BACKGROUND: Lymphatic embolization therapy has proven effective for Fontan failure from plastic bronchitis or protein-losing enteropathy but not when multiple lymphatic compartments are involved; furthermore, embolization does not alter the underlying pathophysiology of lymphatic dysfunction. A technique for transcatheter thoracic duct decompression (TDD), rerouting the thoracic duct to the pulmonary venous atrium to treat multicompartment lymphatic failure is described and early outcomes presented. METHODS: Initially covered stents were used to channel the innominate vein flow inside of the cavopulmonary pathway into the pulmonary venous atrium. A modified approach was developed where covered stents redirected innominate vein directly to the left atrium via an extravascular course. Baseline and follow-up data on all patients undergoing TDD were reviewed. RESULTS: Twelve patients underwent TDD between March 2018 and February 2021 at a median age of 12 (range: 2-22) years. Lymphatic failure occurred in median of 3 compartments per patient (protein-losing enteropathy, ascites, pleural effusions, plastic bronchitis); 10 patients had lymphatic embolizations before TDD. TDD method was intra-Fontan tunnel in 4, direct approach in 7, and other in 1. There were no major procedural complications; 6 patients underwent subsequent procedures, most commonly to treat endoleaks. Lymphatic failure resolved in 6 patients, improved in 2, and was unchanged in 4 at 6 (range: 1-20) months follow-up. One patient died after TDD from Fontan failure. CONCLUSIONS: TDD is a promising new treatment for the failing Fontan physiology from multicompartment lymphatic failure. Additional work is needed to refine the technique and define optimal candidates. |
DOI | 10.1161/CIRCINTERVENTIONS.121.011733 |
Alternate Journal | Circ Cardiovasc Interv |
PubMed ID | 35708032 |